Stockscreener 앱 받기
4.01
0.74%
-0.03
시간 외 거래:
4.00
-0.010
-0.25%
Checkpoint Therapeutics Inc 주식(CKPT)의 최신 뉴스
High Growth Tech Stocks in the US for April 2025 - simplywall.st
3 Growth Companies Insiders Are Betting On - Yahoo Finance
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock - Investing.com India
Checkpoint Therapeutics CEO sells stock for $60,963 - Investing.com India
Checkpoint Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023) - Yahoo Finance
Checkpoint Therapeutics Reports 2024 Financial Results and Merger - TipRanks
Checkpoint Therapeutics Inc. (CKPT) reports earnings - Quartz
Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView
Checkpoint Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - The Manila Times
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint The - GuruFocus
Beryl Capital Management LLC's Strategic Acquisition of Checkpoi - GuruFocus.com
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo Finance
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - Business Wire
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of ... - Bluefield Daily Telegraph
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire Inc.
10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World
Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint
How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma? - Smartkarma
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (NasdaqCKPT), Redfin Corporation (NasdaqRDFN), Amplify Energy Corp. (NYSEAMPY), Blackboxstocks Inc. (NasdaqBL - Morningstar
Sun Pharma to Acquire Checkpoint Therapeutics in Oncology Expansion - Chemical Industry Digest
Checkpoint Therapeutics’ (CKPT) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World
Checkpoint Therapeutics Target of Unusually Large Options Trading (NASDAQ:CKPT) - Defense World
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Major Acquisition Deal in Pharmaceutical Industry: Sun Pharma to Acquire Checkpoint Therapeutics - Dalal Street Investment Journal
Sun Pharma to acquire Checkpoint Therapeutics Inc for up to USD 355 mn - Press Trust of India
Sun Pharma shares rise over 2 pc as company to acquire Checkpoint Therapeutics - Press Trust of India
3 Penny Stocks to Watch Now, 11/3/25 - TipRanks
Checkpoint Therapeutics (NASDAQ:CKPT) Receives Hold Rating from Lake Street Capital - Defense World
Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating - The Financial Express
Sun Pharma to acquire oncology therapy company Checkpoint in US - domain-b.com
Checkpoint Therapeutics (NASDAQ:CKPT) Given Buy Rating at D. Boral Capital - Defense World
Sun Pharma to acquire a US-based oncology firm in a deal exceeding ₹3,000 crore - Bizz Buzz
Despite near-term challenges, brokerages remain positive on Sun Pharma - Business Standard
Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - MSN
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal
Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump - Mugglehead
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Checkpoint Therapeutics, Inc.CKPT - The Malaysian Reserve
Small cap wrap: HIVE, North Bay Resources, GoviEx... - Proactive Investors UK
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details - AOL.com
Checkpoint Therapeutics shares pop on acquisition by Sun Pharma - Proactive Investors UK
Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties (NASDAQ:CKPT) - Seeking Alpha
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher - Benzinga
Sun Pharma to Acquire Checkpoint Therapeutics - Bilkul Online
Checkpoint Therapeutics jumps after deal to be acquired by Sun Pharma - TipRanks
Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com
Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -- Checkpoint Shares Jump Monday - Marketscreener.com
10.70%
자본화:
|
볼륨(24시간):